Onset-of-action for antihistamine and decongestant combinations during an outdoor challenge

Bush, 1997 Naclerio, 1991, Allergic rhinitis, N Engl J Med, 325, 860, 10.1056/NEJM199109193251206 Georgitis, 1999, Allergic rhinitis caused by inhalent factors Simons, 1991, Second-generation H1receptor antagonists, Ann Allergy, 66, 5 Rachelefsky, 1998, Pharmacologic management of allergic rhinitis, J Allergy Clin Immunol, 101, s367, 10.1016/S0091-6749(98)70222-2 Meltzer, 1996, Comparative outdoor study of the efficacy, onset and duration of action, and safety of cetirizine, loratadine and placebo for seasonal allergic rhinitis, J Allergy Clin Immunol, 97, 617, 10.1016/S0091-6749(96)70307-X Day, 1997, Onset of action and efficacy of terfenadine, astemizole, cetirizine, and loratadine for relief of symptoms of allergic rhinitis, Ann Allergy Asthma Immunol, 79, 63, 10.1016/S1081-1206(10)63104-3 Day, 1998, Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit, J Allergy Clin Immunol, 101, 638, 10.1016/S0091-6749(98)70172-1 Day, 1997, Onset of action, efficacy, and safety of a single dose of fexofenadine hydrochloride for ragweed allergy using an environmental exposure unit, Ann Allergy Asthma Immunol, 79, 533, 10.1016/S1081-1206(10)63062-1 Dockhorn, 1987, Safety and efficacy of loratadine (SCH-29851):a new non-sedating antihistamine in seasonal allergic rhinitis, Ann Allergy, 58, 407 Lockey, 1996, Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal allergic rhinitis, Ann Allergy Asthma Immunol, 76, 448, 10.1016/S1081-1206(10)63462-X Donovan, 1996, Efficacy of immunotherapy to ragweed antigen tested by controlled antigen challenge, Ann Allergy Asthma Immunol, 77, 74, 10.1016/S1081-1206(10)63483-7 Day, 1996, A randomized, double-blind, placebo-controlled, controlled antigen delivery study of the onset of action of aerosolized triamcinolone acetonide nasal spray in subjects with ragweed-induced allergic rhinitis, J Allergy Clin Immunol, 97, 1050, 10.1016/S0091-6749(96)70257-9 Del Carpio, 1989, Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis, J Allergy Clin Immunol, 84, 741, 10.1016/0091-6749(89)90303-5 Chervinsky, 1994, Once daily loratadine versus astemizole once daily, Ann Allergy, 73, 109 Simons, 1993, Antihistamines, 856 Abdelaziz, 1998, Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis, J Allergy Clin Immunol, 101, 410, 10.1016/S0091-6749(98)70256-8 Nabe, 1989, Inhibitory effect of terfenadine on mediator release from human blood basophils and eosinophils, Clin Exp Allergy, 19, 515, 10.1111/j.1365-2222.1989.tb02426.x Akagi, 1987, Antiallergic effects of terfenadine on immediate type hypersensitivity reactions, Immunopharmacol Immunotoxicol, 9, 257, 10.3109/08923978709035214 De Vos, 1989, Inhibition of human eosinophil chemotaxis and of the IgE-dependent stimulation of human blood platelets by cetirizine, Int Arch Allergy Appl Immunol, 88, 212, 10.1159/000234789 Kyan-Aung, 1992, The effect of cetirizine on the adhesion of human eosinophils and neutrophils to cultured human umbilical vein endothelial cells, J Allergy Clin Immunol, 90, 270, 10.1016/0091-6749(92)90083-E Miadonna, 1994, Inhibitory effect of the H1 antagonist loratadine on histamine release from human basophils, Int Arch Allergy Appl Immunol, 105, 12, 10.1159/000236797 Lippert, 1995, Czarnetzki BM. Pharmacological modulation of IL-6 and IL-8 secretion by the H1-antagonist decarboethoxyloratadine and dexamethasone by human mast and basophilic cell lines, Exp Dermatol, 4, 272, 10.1111/j.1600-0625.1995.tb00257.x Roquet, 1995, Effects of loratadine on anti-IgE-induced inflammation, histamine release, and leukocyte recruitment in skin of atopies, Allergy, 50, 414, 10.1111/j.1398-9995.1995.tb01171.x Greiff, 1995, Loratadine reduces allergen-induced mucosal output of alpha 2-macroglobulin and tryptase in allergic rhinitis, J Allergy Clin Immunol, 96, 97, 10.1016/S0091-6749(95)70038-2 Miadonna, 1995, Antiallergic activity of loratadine: inhibition of leukotriene C4 release from human leucocytes, Clin Exp Allergy, 25, 364, 10.1111/j.1365-2222.1995.tb01055.x Vignola, 1995, Inhibitory activity of loratadine and descarboethoxyloratadine on expression of ICAM-1 and HLA-DR by nasal epithelial cells, Allergy, 50, 200, 10.1111/j.1398-9995.1995.tb01133.x Roman, 1993, Loratadine. A review of recent findings in pharmacology, pharmacokinetics, efficacy, and safety, with a look at its use in combination with pseudoephedrine, Clin Rev Allergy, 11, 89, 10.1007/BF02802295 Haria, 1994, Loratadine. A reappraisal of its pharmacological properties and therapeutic use in allergic disorders, Drugs, 48, 617, 10.2165/00003495-199448040-00009 Brogden, 1991, Acrivastine. A review of its pharmacological properties and therapeutic efficacy in allergic rhinitis, urticaria and related disorders, Drugs, 41, 927, 10.2165/00003495-199141060-00008 Fleiss, 1985 Dockhorn, 1996, Efficacy of acrivastine with pseudoephedrine in treatment of allergic rhinitis due to ragweed, Ann Allergy Asthma Immunol, 76, 204, 10.1016/S1081-1206(10)63423-0 Anonymous, 1994, Acrivastine/pseudoephedrine (Semprex-D) for seasonal allergic rhinitis, Med Lett Drugs Therap, 36, 78 Meran, 1990, A crossover comparison of acrivastine, pseudoephedrine and their combination in seasonal allergic rhinitis, Rhinology, 28, 33 Williams, 1996, Efficacy of acrivastine plus pseudoephedrine for symptomatic relief of seasonal allergic rhinitis due to mountain cedar, Ann Allergy Asthma Immunol, 76, 432, 10.1016/S1081-1206(10)63460-6 Ramaekers, 1994, Acrivastine, terfenadine and diphenhydramine effects on driving performance as a function of dose and time after dosing, Eur J Clin Pharmacol, 47, 261, 10.1007/BF02570506 Vuurman, 1996, Effects of semprex-D and diphenhydramine on learning in young adults with seasonal allergic rhinitis, Ann Allergy Asthma Immunol, 76, 247, 10.1016/S1081-1206(10)63435-7 Kay, 1997, Initial and steady-state effects of diphenhydramine and loratadine on sedation, cognition, mood, and psychomotor performance, Arch Intern Med, 157, 2350, 10.1001/archinte.157.20.2350 Valk, 1997, Effects of a single dose of loratadine on flying ability under conditions of simulated cabin pressure, Am J Rhinol, 11, 27, 10.2500/105065897781446838 Horak, 1996, Efficacy and tolerability of astemizole-D and Loratadine-D during prolonged, controlled allergen challenge in the Vienna Challenge Chamber, Arzneimittel-Forschung, 46, 1077 Frossard, 1997, Onset of action in the nasal antihistaminic effect of cetirizine and loratadine in patients with allergic rhinitis, Allergy, 52, 205, 10.1111/j.1398-9995.1997.tb00976.x Nielsen, 1994, Efficacy of acrivastine in the treatment of allergic rhinitis during natural pollen exposure: onset of action, Allergy, 49, 630, 10.1111/j.1398-9995.1994.tb00131.x